The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Melinta Therapeutics Inc (MLNT)

Melinta Therapeutics is a commercial-stage pharmaceutical company focused on discovering, developing and commercializing differentiated anti-infectives for infections due to resistant gram-negative and gram-positive bacteria. Co. markets four antibiotics: Baxdela™, for monotherapy treatment of adult patients with acute bacterial skin or skin structure infections (ABSSSI) in oral and intravenous (IV) formulation; Vabomere™, which is for the treatment of complicated urinary tract infections, including pyelonephritis; Orbactiv®, an IV antibiotic for the treatment of adult patients with ABSSSIs; and Minocin for injection, for treatment of Acinetobacter spp.

Company Name:  Melinta Therapeutics Inc
Website:  www.cempra.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding MLNT:  11
Total Market Value Held by ETFs:  $1.32M
Total Market Capitalization:  $38.00M
% of Market Cap. Held by ETFs:  3.48%
May 19, 2019    2:28 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Buy (2.71 out of 4)
25th percentile
(ranked lower than approx. 75% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Melinta Therapeutics Inc (MLNT) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2019, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.